It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Tripartite ATP-independent periplasmic (TRAP) transporters are found widely in bacteria and archaea and consist of three structural domains, a soluble substrate-binding protein (P-domain), and two transmembrane domains (Q- and M-domains). HiSiaPQM and its homologs are TRAP transporters for sialic acid and are essential for host colonization by pathogenic bacteria. Here, we reconstitute HiSiaQM into lipid nanodiscs and use cryo-EM to reveal the structure of a TRAP transporter. It is composed of 16 transmembrane helices that are unexpectedly structurally related to multimeric elevator-type transporters. The idiosyncratic Q-domain of TRAP transporters enables the formation of a monomeric elevator architecture. A model of the tripartite PQM complex is experimentally validated and reveals the coupling of the substrate-binding protein to the transporter domains. We use single-molecule total internal reflection fluorescence (TIRF) microscopy in solid-supported lipid bilayers and surface plasmon resonance to study the formation of the tripartite complex and to investigate the impact of interface mutants. Furthermore, we characterize high-affinity single variable domains on heavy chain (VHH) antibodies that bind to the periplasmic side of HiSiaQM and inhibit sialic acid uptake, providing insight into how TRAP transporter function might be inhibited in vivo.
Tripartite ATP-independent periplasmic (TRAP) transporters are widespread in bacteria and archaea. Here, the authors used cryo-EM and a range of biophysical techniques to study the structure of function of the sialic acid TRAP transporter HiSiaQM.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details













1 University of Bonn, Institute of Structural Biology, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
2 University of Bonn, Institute for Physical und Theoretical Chemistry, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
3 University of Bonn, Institute of Structural Biology, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300); Aston Centre for Membrane Proteins and Lipids Research, Birmingham, UK (GRID:grid.10388.32)
4 University of York, Department of Biology (Area 10), York, UK (GRID:grid.5685.e) (ISNI:0000 0004 1936 9668); Newcastle University, Biosciences Institute, Newcastle, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212)
5 University of York, Department of Biology (Area 10), York, UK (GRID:grid.5685.e) (ISNI:0000 0004 1936 9668)
6 Institut de Génétique et de Biologie Molecule et Cellulaire, Illkirch Cedex, France (GRID:grid.5685.e)
7 University of Regensburg, Institute of Biophysics and Biophysical Chemistry, Regensburg, Germany (GRID:grid.7727.5) (ISNI:0000 0001 2190 5763)
8 University of Bonn, Core Facility Nanobodies, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)